Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE000A0JDBC7
Tue, 06.02.2024
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Preliminary group result 2023 (unaudited) / forecast 2024
Total revenue EUR 37.4m + 26 %
Patient days 46,641 + 26 %
Gross earnings (EBITDA) 7.4 Mio. EUR - 15 %
Operating result (EBIT) 4.7 Mio. EUR - 22 %
Consolidated net income for the period 3,395 kEUR - 30 %
Earnings after minoriti [ … ]
Mon, 18.12.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
LIMES Schlosskliniken expands Management Board
Cologne, December 18, 2023. At its meeting today, the Supervisory Board of LIMES Schlosskliniken AG appointed Dr. Brolund-Spaether (47) to the Management Board with effect from 01.01.2024.
Dr. Brolund-Spaether has been working for LIMES Schlosskliniken as Chief [ … ]
Wed, 12.07.2023
Limes Schlosskliniken AG
DGAP-Adhoc: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG
LIMES Schlosskliniken AG, Cologne/Gaflei, FL, July 12, 2023. LIMES Schlosskliniken AG has acquired 51% of the Liechtenstein private clinic CLINICUM ALPINUM AG via a capital increase. 49% of the shares continue to be held by the [ … ]
Wed, 12.07.2023
Limes Schlosskliniken AG
DGAP-Adhoc: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG
LIMES Schlosskliniken AG, Cologne/Gaflei, FL, July 12, 2023. LIMES Schlosskliniken AG has acquired 51% of the Liechtenstein private clinic CLINICUM ALPINUM AG via a capital increase. 49% of the shares continue to be held by the [ … ]
Wed, 03.05.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
LIMES Schlosskliniken acquires Schlossklinik Abtsee in Berchtesgadener Land / Group development QI
Cologne, May 03, 2023 - LIMES Schlosskliniken AG today acquired the property of Schlossklinik Abtsee from Bergman Deutsche Klinik Laufen GmbH. The previous clinic operation as a vein center with plastic surgery [ … ]
Wed, 03.05.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
LIMES Schlosskliniken acquires Schlossklinik Abtsee in Berchtesgadener Land / Group development QI
Cologne, May 03, 2023 - LIMES Schlosskliniken AG today acquired the property of Schlossklinik Abtsee from Bergman Deutsche Klinik Laufen GmbH. The previous clinic operation as a vein center with plastic surgery [ … ]
Thu, 13.04.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Audited consolidated financial statements 2022 / Approval and adoption of the consolidated financial statements per 31.12.2022 of LIMES Schlosskliniken / Outlook 2023
Total revenue 30.1 Mio. EUR, (p. y. 25.2 Mio. EUR) + 19,1 %
Gross earnings (EBITDA) 8,653 kEUR, (p. y. 6,015 kEUR) + 43,9 %
Operating [ … ]
Thu, 13.04.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Audited consolidated financial statements 2022 / Approval and adoption of the consolidated financial statements per 31.12.2022 of LIMES Schlosskliniken / Outlook 2023
Total revenue 30.1 Mio. EUR, (p. y. 25.2 Mio. EUR) + 19,1 %
Gross earnings (EBITDA) 8,653 kEUR, (p. y. 6,015 kEUR) + 43,9 %
Operating [ … ]
Tue, 23.08.2022
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Positive business development in the first half year 2022
Total earnings EUR 13,4 million +61,3 %
Gross earnings (EBITDA) +4.131 kEUR +81,3 %
Operating result (EBIT) +2.977 kEUR +77,7 %
Result for shareholders of the parent company +1.911 kEUR +23,1 %
Earnings per share +6,52 EUR +23,1 % [ … ]
Tue, 23.08.2022
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Positive business development in the first half year 2022
Total earnings EUR 13,4 million +61,3 %
Gross earnings (EBITDA) +4.131 kEUR +81,3 %
Operating result (EBIT) +2.977 kEUR +77,7 %
Result for shareholders of the parent company +1.911 kEUR +23,1 %
Earnings per share +6,52 EUR +23,1 % [ … ]